Centamin (CELTF)
(Delayed Data from OTC)
$1.46 USD
-0.04 (-2.82%)
Updated Jun 14, 2024 02:35 PM ET
3-Hold of 5 3
A Value C Growth F Momentum B VGM
Income Statements
Fiscal Year end for Centamin falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 891 | 788 | 733 | 829 | 652 |
Cost Of Goods | 597 | 544 | 487 | 449 | 439 |
Gross Profit | 294 | 244 | 246 | 379 | 213 |
Selling & Adminstrative & Depr. & Amort Expenses | 100 | 79 | 63 | 74 | 56 |
Income After Depreciation & Amortization | 194 | 166 | 183 | 306 | 157 |
Non-Operating Income | 4 | 5 | -29 | 9 | 16 |
Interest Expense | 4 | 0 | 0 | 0 | 0 |
Pretax Income | 195 | 171 | 154 | 315 | 173 |
Income Taxes | 0 | 0 | 0 | 0 | 0 |
Minority Interest | 103 | 98 | 52 | 159 | 85 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | 195 | 171 | 154 | 315 | 173 |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
Net Income (GAAP) | 92 | 72 | 102 | 156 | 87 |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | 392 | 312 | 322 | 430 | 274 |
Depreciation & Amortization (Cash Flow) | 198 | 147 | 139 | 125 | 116 |
Income After Depreciation & Amortization | 194 | 166 | 183 | 306 | 157 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 1,180.59 | 1,168.56 | 1,161.96 | 1,159.42 | 1,160.73 |
Diluted EPS Before Non-Recurring Items | 0.08 | 0.06 | 0.09 | 0.13 | 0.08 |
Diluted Net EPS (GAAP) | 0.08 | 0.06 | 0.09 | 0.13 | 0.08 |
Fiscal Year end for Centamin falls in the month of December .
All items in Millions except EPS data.
3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 | |
---|---|---|---|---|---|
Sales | NA | NA | NA | NA | NA |
Cost Of Goods | NA | NA | NA | NA | NA |
Gross Profit | NA | NA | NA | NA | NA |
SG&A, R&D, and Dept/Amort Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Income After SG&A, R&D, and Dept/Amort Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Non-Operating Income | NA | NA | NA | NA | NA |
Interest Expense | NA | NA | NA | NA | NA |
Pretax Income | NA | NA | NA | NA | NA |
Income Taxes | NA | NA | NA | NA | NA |
Minority Interest | NA | NA | NA | NA | NA |
Investment Gains/Losses | NA | NA | NA | NA | NA |
Other Income/Charges | NA | NA | NA | NA | NA |
Income From Cont. Operations | NA | NA | NA | NA | NA |
Extras & Discontinued Operations | NA | NA | NA | NA | NA |
Net Income (GAAP) | NA | NA | NA | NA | NA |
Earnings Per Share Data | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 |
---|---|---|---|---|---|
Average Shares | NA | NA | NA | NA | NA |
Diluted EPS Before Non-Recurring Items | NA | NA | NA | NA | NA |
Diluted Net EPS (GAAP) | NA | NA | NA | NA | NA |